Institute of Bioengineering and Nanotechnology (IBN)
From the public sector to innovative startups and industry giants, A*STAR scholars are blazing the trail across Singapore’s research ecosystem.
Single-cell techniques have helped to identify a key molecular switch controlling how adult cells can be turned back to a stem cell-like state.
Researchers are upcycling plastic waste into antimicrobial products to fight some of the most challenging bacterial infections.
Three A*STAR scholars—Sarah Luo, Caroline Wee, and Kaicheng Liang—have been selected for the highly competitive National Research Foundation Fellowship out of over 134 applicants worldwide.
Curiox Biosystems, an A*STAR spin-off company, specializes in automated and quantitative cell analysis. Its CEO, Namyong Kim, shares the story of the company’s success.
A drug delivery complex derived from green tea could enhance the safety and effectiveness of cancer treatment.
A*STAR researchers have devised a method to generate a renewable source of mature human Kupffer cells for liver toxicity bioassays.
Using an expanded genetic alphabet containing fluorescent artificial DNA bases, scientists can now visually detect and quantify DNA molecules for use in diagnostics.
Cathode material made from organic molecules enhances the green credentials of rechargeable batteries
Generating large numbers of universal immune cells could transform cancer immunotherapy
channel with a strong preference for potassium ions offers rapid transport
through artificial membrane.